文献速递临床试验与 GCP

iTACTIC:创伤性凝血病纠正治疗算法的实施——多中心随机对照试验研究方案

iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial.
PubMed 文献 · Trials · 2017-10-18

本研究为多中心随机对照试验,计划纳入392例成人创伤大出血患者,比较黏弹性止血检测(VHA)指导与优化传统凝血检测(CCT)指导的输血算法在止血效果上的差异。主要终点为24小时内存活且无需大量输血(少于10单位红细胞)的比例。

要点

  • VHA指导与传统CCT指导输血算法的疗效比较尚缺乏充分证据。
  • 主要终点为24小时存活且未接受大量输血(<10单位红细胞)的比例。
  • 计划纳入392例成人创伤患者,随访至出院或28天,存活者90天填写生活质量问卷。

核心结论

  • 传统CCT用于检测创伤性凝血病并监测治疗反应,VHA使用增加但支持其患者中心结局优越性的证据有限,本试验将填补该知识空白。

研究设计与样本

  • 多中心随机对照试验,计划纳入392例成人创伤患者,在各主要创伤中心入组,按中心区组随机分配至VHA指导或CCT指导输血治疗组(均在标准治疗基础上),随访至出院或28天。

主要发现

  • 主要终点为24小时内存活且无需大量输血(少于10单位红细胞)的比例,次要结局包括器官衰竭、总住院和重症监护住院时长、医疗资源需求及死亡率。
  • 存活患者将在第90天完成生活质量问卷(EuroQol EQ-5D™)。

关键数值与推荐

  • 入组标准为出现失血性休克临床征象、启动当地大量出血方案并开始首次输血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traumatic injury is the fourth leading cause of death globally. Half of all trauma deaths are due to bleeding and most of these will occur within 6 h of injury. Haemorrhagic shock following injury has been shown to induce a clotting dysfunction within minutes, and this early trauma-induced coagulopathy (TIC) may exacerbate bleeding and is associated with higher mortality and morbidity. In spite of improved resuscitation strategies over the last decade, current transfusion therapy still fails to correct TIC during ongoing haemorrhage and evidence for the optimal management of bleeding trauma patients is lacking. Recent publications describe increasing the use of Viscoelastic Haemostatic Assays (VHAs) in trauma haemorrhage; however, there is insufficient evidence to support their superiority to conventional coagulation tests (CCTs). METHODS/DESIGN: This multicentre, randomised controlled study will compare the haemostatic effect of an evidence-based VHA-guided versus an optimised CCT-guided transfusion algorithm in haemorrhaging trauma patients. A total of 392 adult trauma patients will be enrolled at major trauma centres. Participants will be eligible if they present with clinical signs of haemorrhagic shock, activate the local massive haemorrhage protocol and initiate first blood transfusion. Enrolled patients will be block randomised per centre to either VHA-guided or CCT-guided transfusion therapy in addition to that therapy delivered as part of standard care, until haemostasis is achieved. Patients will be followed until discharge or 28 days. The primary endpoint is the proportion of subjects alive and free of massive transfusion (less than 10 units of red blood cells) at 24 h. Secondary outcomes include the effect of CCT- versus VHA-guided therapy on organ failure, total hospital and intensive care lengths of stay, health care resources needed and mortality. Surviving patients will be asked to complete a quality of life questionnaire (EuroQol EQ-5DTM) at day 90. DISCUSSION: CCTs have traditionally been used to detect TIC and monitor response to treatment in traumatic major haemorrhage. The use of VHAs is increasing, but limited evidence exists to support the superiority of these technologies (or comparatively) for patient-centred outcomes. This knowledge gap will be addressed by this trial. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02593877 . Registered on 15 October 2015. Trial sponsor Queen Mary University of London The contact person of the above sponsor organisation is: Dr. Sally Burtles, Director of Research Services and Business Development, Joint Research Management Office, QM Innovation Building, 5 Walden Street, London E1 2EF; phone: 020 7882 7260; Email: sponsorsrep@bartshealth.nhs.uk Trial sites Academic Medical Centre, Amsterdam, The Netherlands Kliniken der Stadt Köln gGmbH, Cologne, Germany Rigshospitalet (Copenhagen University Hospital), Copenhagen, Denmark John Radcliff Hospital, Oxford, United Kingdom Oslo University Hospital, Oslo, Norway The Royal London Hospital, London, United Kingdom Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, United Kingdom Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom Sites that are planning to start recruitment in mid/late 2017 Nottingham University Hospitals, Queen's Medical Centre, Nottingham, United Kingdom University of Kansas Hospital (UKH), Kansas City, MO, USA Protocol version: 3.0/14.03.2017 (Additional file 1).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Baksaas-Aasen K, Gall L, Eaglestone S, et al. iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial. Trials. 2017. PMID: 29047413. doi:10.1186/s13063-017-2224-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。